Related Experiment Video
Updated: Jul 23, 2025
A Simple and Inexpensive Method for Determining Cold Sensitivity and Adaptation in Mice
Published on: March 17, 2015
TRPM2 Channels: A Potential Therapeutic Target in Melanoma?
Hattie M Foster1, McKenzie N Carle1, Lukas R Jira1
1Department of Pharmaceutical & Biomedical Sciences, Ohio Northern University, Ada, OH 45810, USA.
Abstract:
The transient receptor potential, the melastatin (TRPM) subfamily, which consists of eight known members, appears to have significant importance in melanoma progression, treatment, and prognosis. As several members were originally cloned from cancerous tissue, initial studies aimed towards identifying TRPM involvement in cancer progression and tumorigenesis. For relevance in skin cancer, previous research has shown roles for several TRPM members in skin cancer progression, growth, and patient prognosis. One unique member, TRPM2, appears to have notable therapeutic potential in the treatment of melanoma. Previous and recent studies have demonstrated increased TRPM2 expression levels in melanoma, as well as important roles for TRPM2 in melanoma growth, proliferation, and survival. TRPM2 is thus an emerging target in the treatment of melanoma, where TRPM2 antagonism may offer an additional treatment option for melanoma patients in the future.
Insights
Transient receptor potential melastatin (TRPM) channels are important in melanoma. TRPM2 shows therapeutic potential, with antagonism offering a future treatment option for melanoma patients.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- The transient receptor potential melastatin (TRPM) subfamily, with eight members, is implicated in melanoma.
- Several TRPM members play roles in skin cancer progression, growth, and patient prognosis.
- TRPM2 is of particular interest due to its potential in melanoma treatment.
Purpose of the Study:
- To investigate the role of TRPM2 in melanoma.
- To explore TRPM2 as a therapeutic target for melanoma.
Main Methods:
- Review of previous and recent studies on TRPM2 expression and function in melanoma.
- Analysis of TRPM2's involvement in melanoma growth, proliferation, and survival.
Main Results:
- Increased TRPM2 expression levels are observed in melanoma.
- TRPM2 plays significant roles in melanoma cell growth, proliferation, and survival.
Conclusions:
- TRPM2 is an emerging therapeutic target for melanoma.
- TRPM2 antagonism may provide a novel treatment strategy for melanoma patients.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:00Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...